These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38293350)

  • 21. Expression of Serum Omentin, CTRP9, and Vaspin in Patients with Polycystic Ovary Syndrome.
    Wang Y; Liu N; Lu J; Yang L; Wang C; Chen J; Chang W
    Evid Based Complement Alternat Med; 2022; 2022():1862404. PubMed ID: 36034953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance.
    Wu YY; Li SY; Zhu HQ; Zhuang ZM; Shao M; Chen FL; Liu CS; Tang QF
    J Ethnopharmacol; 2022 May; 289():115057. PubMed ID: 35121050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin and exenatide upregulate hepatocyte nuclear factor-4α, sex hormone binding globulin levels and improve hepatic triglyceride deposition in polycystic ovary syndrome with insulin resistance rats.
    Xing C; Lv B; Zhao H; Wang D; Li X; He B
    J Steroid Biochem Mol Biol; 2021 Nov; 214():105992. PubMed ID: 34478829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect and mechanism of berberine against polycystic ovary syndrome.
    Zhang SW; Zhou J; Gober HJ; Leung WT; Wang L
    Biomed Pharmacother; 2021 Jun; 138():111468. PubMed ID: 33740526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women.
    Kheirollahi A; Teimouri M; Karimi M; Vatannejad A; Moradi N; Borumandnia N; Sadeghi A
    Lipids Health Dis; 2020 Nov; 19(1):235. PubMed ID: 33161896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of berberine in a rat model of polycystic ovary syndrome mediated via the PI3K/AKT pathway.
    Yu J; Ding C; Hua Z; Jiang X; Wang C
    J Obstet Gynaecol Res; 2021 May; 47(5):1789-1803. PubMed ID: 33709493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.
    Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B
    Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berberine alleviates inflammation in polycystic ovary syndrome by inhibiting hyaluronan synthase 2 expression.
    He S; Li H; Zhang Q; Zhao W; Li W; Dai C; Li B; Cheng J; Wu S; Zhou Z; Yang J; Li S
    Phytomedicine; 2024 Jun; 128():155456. PubMed ID: 38537446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guizhi Fuling Wan, Chinese Herbal Medicine, Ameliorates Insulin Sensitivity in PCOS Model Rats With Insulin Resistance via Remodeling Intestinal Homeostasis.
    Zhu Y; Li Y; Liu M; Hu X; Zhu H
    Front Endocrinol (Lausanne); 2020; 11():575. PubMed ID: 32973686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 33. Pioglitazone can improve liver sex hormone-binding globulin levels and lipid metabolism in polycystic ovary syndrome by regulating hepatocyte nuclear factor-4α.
    Zhao H; Wang D; Xing C; Lv B; Wang X; He B
    J Steroid Biochem Mol Biol; 2023 May; 229():106265. PubMed ID: 36737028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome.
    Seow KM; Ting CH; Huang SW; Ho LT; Juan CC
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kuntai capsules improve glucolipid metabolism in patients with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Liang R; Liu Z; Li P; Fan P; Xu L; Sun X; Peng J; Peng X; Zhang M
    Medicine (Baltimore); 2019 Sep; 98(39):e16788. PubMed ID: 31574794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome.
    Yang H; Lin J; Li H; Liu Z; Chen X; Chen Q
    Front Endocrinol (Lausanne); 2021; 12():571229. PubMed ID: 33716958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of Insulin Resistance, Lipid Profile and Glucose Metabolism Associated with Polycystic Ovary Syndrome by
    Rani R; Chitme HR; Kukreti N; Pant P; Abdel-Wahab BA; Khateeb MM; Habeeb MS; Bakir MB
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242122
    [No Abstract]   [Full Text] [Related]  

  • 39. Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease.
    Zhang J; Hu J; Zhang C; Jiao Y; Kong X; Wang W
    Exp Ther Med; 2018 May; 15(5):4259-4264. PubMed ID: 29725371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased Insulin Resistance by Myo-Inositol Is Associated with Suppressed Interleukin 6/Phospho-STAT3 Signaling in a Rat Polycystic Ovary Syndrome Model.
    Zhang Y; Li C; Zhang W; Zheng X; Chen X
    J Med Food; 2020 Apr; 23(4):375-387. PubMed ID: 32045334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.